PYC pyc therapeutics limited

The following link is to an interview with Roche's Head of...

  1. SoT
    858 Posts.
    lightbulb Created with Sketch. 107
    The following link is to an interview with Roche's Head of Discovery Chemistry, Torsten Hoffmann.

    The interview is titled "Exploring Opportunities in Chemical Biology".

    http://www.businesswire.com/news/home/20101128005024/en/F.-Hoffmann---La-Roche-Exploring-Opportunities


    Hoffmann says pharma need to explore Chemical Biology approaches in much greater detail.

    When asked what areas of Chemical Biology, his first reply is:

    " One area is certainly the delivery of non-permeable molecules and macromolecules into cytoplasm and into the cell nucleus. What we would have to explore here are active and passive transport mechanisms, endo- or transcytosis, artifical viruses, and cell penetrating peptide motives...."

    ....................
    Getting drugs into cells seems to be Roche's main focus.

    Cell penetrating peptides are what PYC went searching for in stage 1 and PYC are happy with the results.

    Roche will give PYC wings.
    Cheers ST
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.36
Change
0.005(0.37%)
Mkt cap ! $793.2M
Open High Low Value Volume
$1.40 $1.40 $1.36 $211.9K 152.9K

Buyers (Bids)

No. Vol. Price($)
1 4103 $1.36
 

Sellers (Offers)

Price($) Vol. No.
$1.39 2028 1
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.